GCS Physician Dr. Rodolfo Bordoni Featured in Local News Story on Lung Cancer Research

Tuesday, December 11th, 2012

Rodolfo Bordoni, MDDecember 7, 2012 (ATLANTA) — Dr. Rodolfo Bordoni of Georgia Cancer Specialists (GCS)—a Top 10 private cancer practice in the U.S.— was interviewed by CBS Atlanta’s Jennifer Mayerle for a special report on a new drug that is bringing hope to lung cancer patients. Dr. Bordoni’s patient, Ankit Patel, learned that he had stage IV lung cancer after complaining of shoulder pain. The 29-year-old and his physicians were shocked to find that it was lung cancer, considering he is a non-smoker, is young, and leads a generally healthy lifestyle. Ankit Patel is part of the roughly 15 percent of nonsmoking patients diagnosed with lung cancer. He suffers from a rare genetic mutation referred to as EML4-ALK. Patel takes the targeted therapy drug, Crizotinib, which was approved by the FDA last year. Several GCS patients were enrolled in the clinical research trials of the drug. Dr. Bordoni said, “Just with a single pill one or two times a day, patients go from being in a wheelchair and come to the next consult a month later walking and enjoying life.” Lung cancer is the leading cause of cancer death in this country for men and women, claming more than 150,000 lives each year. Traditionally, people who use tobacco are associated with a lung cancer diagnosis, but more and more nonsmokers have the disease. Watch the interview and read the full story here: http://www.cbsatlanta.com/story/20140738/new-pill-brings-new-hope-for-some-lung-cancer-patients Georgia Cancer Specialists is a Top 10 private cancer practice in the U.S. and a leader in advanced cancer treatment and research. The practice supports more than 200,000 patient visits each year. GCS offers community-based medical oncology and hematology services and is the first private oncology practice to also provide a full range of support services for patients in Georgia, including wellness counseling and home health coordination. The GCS research department, whose focus is bringing targeted cancer therapy to communities, is the first in Georgia to offer Phase I clinical trials, the most novel cancer therapies available. GCS has 29 offices, 45 physicians, and more than 500 support staff members located in Metro Atlanta, and North and Central Georgia. Georgia Cancer Specialists can be found on the web at www.gacancer.com GCS is The Cancer Answer

© 2022, GEORGIA CANCER SPECIALISTS Administrative Annex . All Rights Reserved.